Keywords: thrombogenics, reports, vitrectomy, study, leuven, belgium-based, announced

Thrombogenics reports on vitrectomy study

Article | 07 July 2008

Leuven, Belgium-based ThromboGenics announced positive results from the MIVI III trial of microplasmin in vitrectomy at the World Ophthalmology Congress ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing